Sign in

CIK 0001708599 · Non-accelerated filer<br>Smaller reporting company

Serina Therapeutics, Inc.

Sign in to watch
Ticker
SER
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
AL
Entity type
operating
EIN
821436829
Phone
(256) 327-9630
Business address
601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
Former names
AgeX Therapeutics, Inc.
  1. 4 Open-market buy Director bought 19,200 shares at an average $7.30 ($140,116)
  2. 4 Open-market buy Director bought 8,943 shares at $6.59 ($58,928)
  3. 4 Open-market buy Director bought 6,400 shares at $7.07 ($45,228)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market buy Director bought 7,600 shares at an average $9.33 ($70,900)
  7. 4 Open-market buy Director bought 6,378 shares at $9.50 ($60,591)
  8. 4 Open-market buy Director bought 9,019 shares at $9.50 ($85,681)
  9. 4 Open-market buy Director bought 3,287 shares at $9.50 ($31,227)
  10. 4 Open-market buy Director bought 12,380 shares at an average $9.76 ($120,827)
  11. 4 Open-market buy Director bought 1,422 shares at $9.50 ($13,509)
  12. 4 Open-market buy Director bought 100 shares at $9.00 ($900)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 5 of 9 · 177 filings